"Efgartigimod je "prva u klasi" terapija ciljanje FcRn, dizajniran za smanjenje
patogenih IgG antitijela i blokirati IgG recikliranje proces. Uloga FcRn receptora je spriječiti razgradnju IgG. Stoga, sprečavanjem vezivanja IgG i FcRn, IgG antitijela koja posreduju autoimune bolesti mogu se brže iscrpiti, čime se smanjuju simptomi bolesti." http://hr.hsp-pharma.com/info/67-of-patients-have-significantly-improved-sy- 46349492.html
"FcRn functions as a recycling or transcytosis receptor that is responsible for
maintaining IgG and albumin in the circulation, and bidirectionally transporting these two ligands across polarized cellular barriers." https://pubmed.ncbi.nlm.nih.gov/31354709/